Sernova Enters Into Exclusive Worldwide License Agreement with University of Miami

Ontario Industry Updates
Written By Guest User
Av7FEx6M.png

Sernova Corp., a clinical-stage regenerative medicine company developing a 'functional cure' for type 1 diabetes and other chronic diseases, announced today it has entered into an exclusive, worldwide license with the University of Miami at Coral Gables, Florida, for the commercial rights to novel conformal coating immune protection technologies. 

Guest User
Previous

Curiato Presents at International Medical Conference
Next

Ted Sargent Named University of Toronto Vice President, Research and Innovation and Strategic Initiatives